4
Changes in Ownership
agilon health, inc. Filed Acc 0001209191-23-025112
Chief Strategy & Dev. Officer sold 5,500 shares at an average $26.84 ($147,618)
- Chief Strategy & Dev. Officer acquired 5,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Desai Veeral Chief Strategy & Dev. Officer | 2023-04-19 | Option exercise 10b5-1 | +5,000 | $3.00 | $15,000 | 304,585 | D: show line 1 in the form |
| Desai Veeral Chief Strategy & Dev. Officer | 2023-04-19 | Sale 10b5-1 | −4,545 | $26.82 | $121,877 | 300,040 | D: show line 2 in the form |
| Desai Veeral Chief Strategy & Dev. Officer | 2023-04-19 | Sale 10b5-1 | −455 | $27.84 | $12,666 | 299,585 | D: show line 3 in the form |
| Desai Veeral Chief Strategy & Dev. Officer | 2023-04-20 | Option exercise 10b5-1 | +500 | $3.00 | $1,500 | 300,085 | D: show line 4 in the form |
| Desai Veeral Chief Strategy & Dev. Officer | 2023-04-20 | Sale 10b5-1 | −500 | $26.15 | $13,074 | 299,585 | D: show line 5 in the form |
| Open-market sales · 5,500 sh · avg $26.84 · $147,618 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Desai Veeral Chief Strategy & Dev. Officer | 2023-04-19 | Option exercise · Options (Rights to Buy) 10b5-1 | −5,000 | 1,515,000 | D: show line 6 in the form | ||
| Desai Veeral Chief Strategy & Dev. Officer | 2023-04-20 | Option exercise · Options (Rights to Buy) 10b5-1 | −500 | 1,514,500 | D: show line 7 in the form |
Loading xslF345X04/doc4.xml…